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making them possible, if not likely, targets for this growth factor. 
Because many of these cytoldnes and growth factors are potent 
chemoattractants for smooth muscle, particularly PDGF, many of 
the smooth muscle cells may be chemotactically attracted to 
migrate from the media into the intima. This could result from the 
formation of chemotactic factors, such as PDGF-BB, by the foam 
cells and possibly by the overlying endothelial cells. 
Thus a series of cellular interactions among monocyte-derived 
macrophages, T lymphocytes, overlying endothelial ceils, and 
subjacent smooth muscle cells can lead to the migration and intimal 
localization ofmacrophages and smooth muscle cells, which then 
can go on to replicate as a result of the presence of numerous 
growth-stimulatory molecules, uch as monocyte-colony sthnulat- 
ing factor (M-CSF), PDGF, and ItB-EGF. Furthermore, the 
release of cytokines, such as IL-1 and TNF, and other growth- 
regulatory molecules, uch as TGF[3, could lead to gene expression 
on the part of the smooth muscle cells of additional PDGF. The 
presence of TGF~ and its exposure to the smooth muscle cells could 
lead to stimulation of formation of connective tissue matrix 
constituents, including proteoglycans, collagen, and elastic fiber 
proteins by the smooth muscle cells within the neoinrima. Thus the 
net result of the different cellular interactions and the genes 
expressed by these cells could lead to a macrophage-smooth muscle 
fibroproliferative r sponse characteristic of those observed with 
long-term atherogenesis. 
ApoE-deficient mice 
Apolipoprotein (Apo).E-deficient transgenic mice develop 
severe hypercholesterolemia due to delayed clearance of large 
atherogenic particles from the circulation. These animals will 
develop lesions of atherosclerosis on a chow diet and accelerated 
lesions on a Western-type high fat diet. Lesions of atherosclerosis 
develop similarly to those described in human beings and most 
experimental animal models. Adhesion molecules, including 
ICAM-1 and VCAM-1, form at sites of low shear and high 
turbulence throughout the arterial tree, such as at branches and 
bifurcations. ICAM- 1 is normally present at these sites in wild-type 
animals, as well as in ApoE-deficient mice, but becomes up- 
regulated at the same sites in the ApoE-deficient mice. VCAM-1, 
on the other hand, appears with hypercholesterolemia coincident 
with the attachment of mononuclear ceils at these same sites. They 
enter into the artery wall, take up the lipid within the wall, and 
become foam cells, establishing fatty streaks at these sites. In older 
animals the same sites contain internaediate or advanced lesions, 
such as fibrous plaques and complicated lesions. The complicated 
lesions contain fibrous caps covering anecrotic ore and all of the 
cell types observed in human lesions in the same relative positions. 
Occlusive lesions of coronary arteries have been found, although to 
date no infarcts were observed, but  myocardial fibrosis has been 
noted. These animals thus represent a small murine model of 
atherogenesis that demonstrates many similarities with the human 
condition that should prove valuable in probing the process of 
atherogenesis and in testing approaches to treatment and preven- 
tion of this disease process. 
Response to injury and excess in a 
protective response 
Thus observations in experimentally-induced atherosclerosis 
and during various aspects of the progression ofthis disease support 
the response-to-injury hypothesis ofatherosclerosis that some form 
of damage (subtle or otherwise) to the endothelium leads to a series 
of cellular interactions that culminate in the process of atherogen- 
esis. The initial inflammatory process that is succeeded by migration 
and proliferation of lnonocytes and smooth muscle cells involves 
the establishment of a network of communication among the 
monocytes, mooth muscle cells, and the T lymphocytes that may 
be present in the lesions. Gene expression by each of these cell types 
will depend on local factors present within the microenvironment 
and will determine which stimulatory or inhibitory growth-regu- 
latory molecules and cytokines will be formed by these interacting 
cells. All of these vents appear to be associated with some form of 
injury and wound repair in a specialized tissue, such as the artery. 
Under most circumstances, if the injury and repair were optimal, 
the healing events would be followed by a somewhat s rengthened 
artery with no thickening of the artery wall. If, on the other hand, 
the injury is chronic and prolonged, as would be the case in 
individuals with chronic hyperlipidemia, hypertension, diabetes, 
cigarette smoking, or combinations of these risk factors, then it is 
conceivable that the injury-repair phenomenon may become x- 
cessive with time, leading to thickening of the wall, to alterations 
within the artery that could lead to localized thrombosis, and 
ultimately to occlusive lesions ofatherosclerosis. There is increasing 
evidence that the inflammation that may occur at the shoulders of 
the progressing, enlarged lesions of atherosclerosis may be sites in 
the artery that may be most susceptible to injury and thus subject 
to platelet interactions, mural thrombosis, and even fissuring or 
ulceration of the lesions that could lead to the formation of 
occlusive thrombi. Thus, in all of these respects, what may begin as 
a protective, inflammatory response may become an excessive 
response that ultimately becomes a disease process itself. 
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TRANSPLANTATION ATHEROSCLEROSIS :  
INS IGHT FROM ANIMAL MODELS 
The development of an accelerated form of arteriosclerosis cur- 
rently limits the long-term survival of solid organ allografts in 
humans. Various animal preparations permit study of the patho- 
genesis of transplantation arteriosclerosis. In general, these models 
combine allogeneic transplantation f a vascularized graft with 
manipulations that limit acute rejection (e.g., selection of weakly- 
reactive strain combinations or pharmacologic mmunosuppres- 
sion). This approach recapitulates lements of human transplanta- 
tion that produce transplantation arteriosclerosis. Rabbits and rats 
are convenient animals for technical reasons. Studies from our 
laboratory and many others have used these preparations to gain 
insight into the pathogenesis of graft vascular disease. 1,2 Despite 
their utility, the inability to alter conveniently the genetic make-up 
of these species has limited this type of experiment. Incomplete 
genetic characterization, relative lack of species-appropriate re- 
agents, and the paucity or absence of congenic strains further 
restrict he experiments possible with these species. For example, 
the lack of inbred strains in rabbits precludes isograft controls, 
which could permit he investigation ofnonimmune injury, (e.g., 
related to graft ischemia before implantation). 
Mouse models, although technically more challenging, offer 
unique opportunities toexamine mechanisms because of the wealth 
of knowledge and reagents related to mouse immunology and 
immunogenetics and the emerging availability of genetically altered 
strains of mice that will permit critical testing of hypotheses in vivo. 
Two mouse transplant models that appear useful are the hetero- 
topic heart ransplants (cervical or abdominal) and arterial inter- 
JOURNAL OF VASCULAR SURGERY 
Volume 24, Number 1 SpeciM Communication 151 
position grafts, a 6 Both models have produced lesions that resemble 
human transplantation arteriosclerosis. 
The recent availability of many mutant mice that have specific 
targeted gene disruptions generated by homologous recombina- 
tion (gene "knockout") illustrates the particular value of mice. For 
technical reasons, homologous recombination has generally used 
embryonic stem (ES) cells from the 129 strain, and the mutations 
must be subsequently bred into more conventional strains for use 
in immunologic experiments. The availability of ES cells from other 
strains may obviate this inconvenience. Many such animals are now 
widely available in the research community, a number of which bear 
particular interest for analysis of the immune mechanisms of 
transplantation arteriosclerosis. Efforts are currently underway in 
several laboratories toexploit his approach to learn more about he 
pathogenesis of graft vascular disease. 
Peter Libby, MD 
Brigham and Women's Hospital 
Boston, Mass. 
REFERENCES 
1. Tanaka H, Snkhova G, Libby P. Interaction of the allogeneic 
state and hypercholesterolemia in rterial lesion formation in 
experimental cardiac allografts. Arterioscler Thromb Vase Biol 
1994;14:73-5. 
2. Tanaka H, Swancon S, Sulchova G, Schoen P, Libby R Smooth 
muscle cells of the coronary arterial tunica media express tumor 
necrosis factor alpha and proliferate during acute rejection of 
rabbit cardiac allografts. Am J Pathol 1995;147:617-26. 
3. Corry R, Winn H, Russell P. Primarily vascularized allografts of 
hearts in mice. Transplantation 1973;16:343-50. 
4. Russell PS, Chase CM, Winn HI, Colvin RB. Coronary ar- 
therosclerosis in transplanted mouse hearts. I Time course and 
immunogenetic and immunopathological onsiderations. Am J 
Pathol 1994;144;260-74. 
5. Matsuura A, Abe T, Yasuura K. Simplified mouse cervical heart 
transplantation using a cuff technique. Transplantation 1991; 
51:896-8. 
6. Shi C, Russell M, Bianchi C, Newell J, Haber E. A murine model 
of accelerated transplant arteriosclerosis. Circ Res 1994;75: 
199-207. 
MURINE MODELS OF 
FIBRINOLYTIC D ISORDERS 
Object ives  
The plasminogen/plasmin system, via its triggers, tissue-type 
plasminogen activator (t-PA) and urokinase-type plasminogen 
activator (u-PA) and its inhibitor, plasminogen activator inhibitor- 1
(PAI-1), has been presumed to be implicated in arterial restenosis 
after vascular econstruction i patients with atherothrombotic 
disease. This study performed in mice with targeted gene inactiva- 
tion of t-PA, u-PA, PAI-1, the urokinase receptor (u-PAR) and 
plasminogen (Pig) reveals that vascular injury-induced neointima 
formation is reduced in mice that lack uPA-mediated plasmin 
proteolysis unaltered int-PA-deficient or u-PAR-deficient mice and 
accelerated in PAI-1 deficient mice, most likely by means of a 
mechanism of reduced cell migration combined with unaffected 
cell proliferation. These findings were extended by adenovirus- 
mediated gene transfer of PAI-I in PAI-1 deficient mice, which 
inhibits neointima formation to the same degree as observed in 
u-PA deficient mice. Thus inhibition ofu-PA activity in the injured 
vessel wall might prevent or delay arterial neointima formation. 
Surprisingly, u-PA does not require binding to its cellular eceptor 
herefore, questioning the in vivo role of u-PAR. 
In t roduct ion  
The plasminogen system comprises an inactive proenzyme, 
plasminogen (Plg), that is converted to the proteolytic enzyme 
plasmin by two physiologic plasminogen activators, tissue-type 
plasminogen activator (t-PA) and uroldnase-type plasminogen 
activator (u-PA).l Inhibition of the fibrinolytic system may occur at 
the level ofplasmin, mainly by a 2 antiplasmin, orat the level of the 
plasminogen activators by specific plasminogen activator inhibitors 
(PAIs), of which PAI~I appears to be the principal inhibitor. 2 t-PA 
is believed to be ptimarily responsible for removal of fibrin from the 
vascular tree through its specific affinity for fibrin) u~PA binds to a 
cellular receptor (u-PAR) and might participate in pericellular 
proteolysis by means of degradation of matrix components or via 
activation of latent proteinases or growth factors. 3 Cell-specific 
clearance ofplasminogen activators by LDL receptor-related pro- 
tein (LRP) or gp330 might constitute a mechanism to modulate 
pericelhilar plasmin proteolysis. 
Vascular econstructions, including coronary angioplasty, en- 
darterectomy, bypass urgery, vascular stents, and heart ransplan- 
tation, have become widely used treatments for patients with 
atherothrombotic d sease. However, chronic restenosis n 30% to 
50% of patients, necessitating costly and complicated reinterven- 
tions, remains amajor limitation of these procedures. Elastic recoil, 
adventitial remodeling, and thrombosis have been implicated in the 
process. Kestcnosis i , however, frequently characterized byexces- 
sive accumulation of smooth muscle cells and deposition of 
extracellular matrix in the intimal ayer due to an uncontrolled 
wound healing process in response to vascular trauma. Recently, 
evidence has been provided for a significant role of the plasminogen 
system in vascular wound healing. In an uninjured vessel, expres- 
sion oft-PA by endothelial cells and, to a variable xtent, of PAI-1 
by medial smooth muscle cells suggests a role in maintaining 
vascular patency and hemostasis, respectively. 4-6 After transient 
reduction oft-PA as a result of endothelial cell damage, u-PA and 
t-PA activity in the vessel wall are significantly increased, coincident 
with the time of smooth muscle cell proliferation and migration, 
respectively. 7-9 This increase in plasmin proteolysis appears to be 
counterbalanced by enhanced expression of PAI-1 in injured 
smooth muscle and endothelial cells or by its release from accumu- 
lating platelets. 7,1°,n Expression of fibrinolytic system components 
is also induced by wounding or treatment of cultured endothelial 
cells, smooth muscle cells, or macrophages with growth factors and 
cytokines that are released after injury, 12a3 further supporting a
possible role of this proteinase system in vivo. Local increases of 
plasmin proteolysis n the injured vessel may participate in clot lysis 
( a possible mediator of neointima formation), in passivation ofthe 
injured vessel lumen, or in matrix remodeling. In addition, plas- 
minogen activators have been implicated in migration as well as 
proliferation of vascular cells in vitro and in vivo. 7-9'14 
Resu l ts  and  d iscuss ion  
Arterial neointima formation was induced in mice with inac- 
tivated genes oft-PA, u-PA, u-PAR, Pig, PAI-1 or with combined 
deficiency of t-PA and u-PA, lsq9 using either an intraluminai 
guidewire to overextend and scratch the vessel (mechanical trauma) 
or externally applied electric current o deplete a defined vessel 
fragment of viable cells (electric injury). Electric injury of carotid 
and femoral arteries from wild-type (WT) mice resulted in total 
cellular necrosis across the vessel wall with associated periadventitial 
inflammation and formation of intravascular thrombosis, as re- 
